Lung Disease Therapeutics Market By Disease Type (Asthma, COPD, Lung Cancer, Other Diseases), By Treatment Type (Drugs, Bronchodilators, Antibiotics, Anti-inflammatory Agents, Oxygen Therapy, Other Treatment Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Apr 2024
Report ID: 118403
Number of Pages:
Format:

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    2.2.1. Drivers
    2.2.2. Restraints
    2.2.3. Opportunities
    2.2.4. Key Lung Disease Therapeutics Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    2.9.1. List of Raw Materials Suppliers
    2.9.2. List of Lung Disease Therapeutics Manufacturers
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Lung Disease Therapeutics Market Analysis and Forecast, By Segment, 2018-2033
  - 3.1. Key Findings
  - 3.2. Global Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Type, 2018-2033
  - 3.3. Global Lung Disease Therapeutics Market Attractiveness Analysis, By Disease Type
    3.3.1. Asthma
    3.3.1.1. Insights
    3.3.1.2. Key Takeaways
    3.3.2. COPD
    3.3.2.1. Insights
    3.3.2.2. Key Takeaways
    3.3.3. Lung Cancer
    3.3.3.1. Insights
    3.3.3.2. Key Takeaways
    3.3.4. Other Diseases
    3.3.4.1. Insights
    3.3.4.2. Key Takeaways
  - 3.4. Global Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2018-2033
  - 3.5. Global Lung Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
    3.5.1. Drugs
    3.5.1.1. Insights
    3.5.1.2. Key Takeaways
    3.5.2. Bronchodilators
    3.5.2.1. Insights
    3.5.2.2. Key Takeaways
    3.5.3. Antibiotics
    3.5.3.1. Insights
    3.5.3.2. Key Takeaways
    3.5.4. Anti-inflammatory Agents
    3.5.4.1. Insights
    3.5.4.2. Key Takeaways
    3.5.5. Oxygen Therapy
    3.5.5.1. Insights
    3.5.5.2. Key Takeaways
    3.5.6. Other Treatment Types
    3.5.6.1. Insights
    3.5.6.2. Key Takeaways
  - 3.6. Global Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2018-2033
  - 3.7. Global Lung Disease Therapeutics Market Attractiveness Analysis, By Distribution Channel
    3.7.1. Retail Pharmacies
    3.7.1.1. Insights
    3.7.1.2. Key Takeaways
    3.7.2. Hospital Pharmacies
    3.7.2.1. Insights
    3.7.2.2. Key Takeaways
    3.7.3. Online Pharmacies
    3.7.3.1. Insights
    3.7.3.2. Key Takeaways
- 4. Global Lung Disease Therapeutics Market Analysis and Forecast, By Region, 2018-2033
  - 4.1. Key Findings
  - 4.2. Global Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2018-2033
    4.2.1. North America
    4.2.1.1. Regional Insights
    4.2.2. Europe
    4.2.2.1. Regional Insights
    4.2.3. Asia Pacific
    4.2.3.1. Regional Insights
    4.2.4. Latin America
    4.2.4.1. Regional Insights
    4.2.5. Middle East & Africa
    4.2.5.1. Regional Insights
  - 4.3. Global Lung Disease Therapeutics Market Attractiveness Analysis, By Region
- 5. North America Lung Disease Therapeutics Market Analysis and Forecast, 2018-2033
  - 5.1. Key Findings
  - 5.2. North America Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Type, 2018-2033
  - 5.3. North America Lung Disease Therapeutics Market Attractiveness Analysis, By Disease Type
  - 5.4. North America Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2018-2033
  - 5.5. North America Lung Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
  - 5.6. North America Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2018-2033
  - 5.7. North America Lung Disease Therapeutics Market Attractiveness Analysis, By Distribution Channel
  - 5.8. North America Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 5.9. North America Lung Disease Therapeutics Market Attractiveness Analysis, By Country
    5.9.1. The US
    5.9.2. Canada
- 6. Europe Lung Disease Therapeutics Market Analysis and Forecast, 2018-2033
  - 6.1. Key Findings
  - 6.2. Europe Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Type, 2018-2033
  - 6.3. Europe Lung Disease Therapeutics Market Attractiveness Analysis, By Disease Type
  - 6.4. Europe Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2018-2033
  - 6.5. Europe Lung Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
  - 6.6. Europe Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2018-2033
  - 6.7. Europe Lung Disease Therapeutics Market Attractiveness Analysis, By Distribution Channel
  - 6.8. Europe Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 6.9. Europe Lung Disease Therapeutics Market Attractiveness Analysis, By Country
    6.9.1. Germany
    6.9.2. The UK
    6.9.3. France
    6.9.4. Spain
    6.9.5. Italy
    6.9.6. Russia
    6.9.7. Netherlands
    6.9.8. Rest of Europe
- 7. Asia Pacific Lung Disease Therapeutics Market Analysis and Forecast, 2018-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Type, 2018-2033
  - 7.3. Asia Pacific Lung Disease Therapeutics Market Attractiveness Analysis, By Disease Type
  - 7.4. Asia Pacific Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2018-2033
  - 7.5. Asia Pacific Lung Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
  - 7.6. Asia Pacific Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2018-2033
  - 7.7. Asia Pacific Lung Disease Therapeutics Market Attractiveness Analysis, By Distribution Channel
  - 7.8. Asia Pacific Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 7.9. Asia Pacific Lung Disease Therapeutics Market Attractiveness Analysis, By Country
    7.9.1. China
    7.9.2. Japan
    7.9.3. South Korea
    7.9.4. India
    7.9.5. New Zealand
    7.9.6. Singapore
    7.9.7. Thailand
    7.9.8. Vietnam
    7.9.9. Rest of Asia Pacific
- 8. Latin America Lung Disease Therapeutics Market Analysis and Forecast, 2018-2033
  - 8.1. Key Findings
  - 8.2. Latin America Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Type, 2018-2033
  - 8.3. Latin America Lung Disease Therapeutics Market Attractiveness Analysis, By Disease Type
  - 8.4. Latin America Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2018-2033
  - 8.5. Latin America Lung Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
  - 8.6. Latin America Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2018-2033
  - 8.7. Latin America Lung Disease Therapeutics Market Attractiveness Analysis, By Distribution Channel
  - 8.8. Latin America Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 8.9. Latin America Lung Disease Therapeutics Market Attractiveness Analysis, By Country
    8.9.1. Brazil
    8.9.2. Mexico
    8.9.3. Rest of Latin America
- 9. Middle East & Africa Lung Disease Therapeutics Market Analysis and Forecast, 2018-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Type, 2018-2033
  - 9.3. Middle East & Africa Lung Disease Therapeutics Market Attractiveness Analysis, By Disease Type
  - 9.4. Middle East & Africa Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Type, 2018-2033
  - 9.5. Middle East & Africa Lung Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
  - 9.6. Middle East & Africa Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2018-2033
  - 9.7. Middle East & Africa Lung Disease Therapeutics Market Attractiveness Analysis, By Distribution Channel
  - 9.8. Middle East & Africa Lung Disease Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 9.9. Middle East & Africa Lung Disease Therapeutics Market Attractiveness Analysis, By Country
    9.9.1. South Africa
    9.9.2. Saudi Arabia
    9.9.3. UAE
    9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    10.7.1. GlaxoSmithKline
    10.7.1.1. Company Details
    10.7.1.2. Business Overview
    10.7.1.3. Disease Type Portfolio
    10.7.1.4. Financial Insights
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Disease Type Development)
    10.7.1.6. SWOT Analysis
    10.7.1.7. Geographic Footprint
    10.7.2. Boehringer Ingelheim
    10.7.2.1. Company Details
    10.7.2.2. Business Overview
    10.7.2.3. Disease Type Portfolio
    10.7.2.4. Financial Insights
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Disease Type Development)
    10.7.2.6. SWOT Analysis
    10.7.2.7. Geographic Footprint
    10.7.3. AstraZeneca
    10.7.3.1. Company Details
    10.7.3.2. Business Overview
    10.7.3.3. Disease Type Portfolio
    10.7.3.4. Financial Insights
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Disease Type Development)
    10.7.3.6. SWOT Analysis
    10.7.3.7. Geographic Footprint
    10.7.4. Novartis
    10.7.4.1. Company Details
    10.7.4.2. Business Overview
    10.7.4.3. Disease Type Portfolio
    10.7.4.4. Financial Insights
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Disease Type Development)
    10.7.4.6. SWOT Analysis
    10.7.4.7. Geographic Footprint
    10.7.5. Sanofi
    10.7.5.1. Company Details
    10.7.5.2. Business Overview
    10.7.5.3. Disease Type Portfolio
    10.7.5.4. Financial Insights
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Disease Type Development)
    10.7.5.6. SWOT Analysis
    10.7.5.7. Geographic Footprint
    10.7.6. Cipla
    10.7.6.1. Company Details
    10.7.6.2. Business Overview
    10.7.6.3. Disease Type Portfolio
    10.7.6.4. Financial Insights
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Disease Type Development)
    10.7.6.6. SWOT Analysis
    10.7.6.7. Geographic Footprint
    10.7.7. F. Hoffman La Roche
    10.7.7.1. Company Details
    10.7.7.2. Business Overview
    10.7.7.3. Disease Type Portfolio
    10.7.7.4. Financial Insights
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Disease Type Development)
    10.7.7.6. SWOT Analysis
    10.7.7.7. Geographic Footprint
    10.7.8. Teva Pharmaceuticals
    10.7.8.1. Company Details
    10.7.8.2. Business Overview
    10.7.8.3. Disease Type Portfolio
    10.7.8.4. Financial Insights
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Disease Type Development)
    10.7.8.6. SWOT Analysis
    10.7.8.7. Geographic Footprint
    10.7.9. Astellas Pharma
    10.7.9.1. Company Details
    10.7.9.2. Business Overview
    10.7.9.3. Disease Type Portfolio
    10.7.9.4. Financial Insights
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Disease Type Development)
    10.7.9.6. SWOT Analysis
    10.7.9.7. Geographic Footprint
    10.7.10. Other Key Players
    10.7.10.1. Company Details
    10.7.10.2. Business Overview
    10.7.10.3. Disease Type Portfolio
    10.7.10.4. Financial Insights
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Disease Type Development)
    10.7.10.6. SWOT Analysis
    10.7.10.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
- List of Tables
  - Table 1. Global Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 2. Global Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 3. Global Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 4. Global Lung Disease Therapeutics Market Value (US$ Mn), By Region, 2018-2033
  - Table 5. North America Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 6. North America Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 7. North America Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 8. North America Lung Disease Therapeutics Market Value (US$ Mn), By Country, 2018-2033
  - Table 9. The US Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 10. The US Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 11. The US Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 12. Canada Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 13. Canada Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 14. Canada Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 15. Europe Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 16. Europe Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 17. Europe Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 18. Europe Lung Disease Therapeutics Market Value (US$ Mn), By Country, 2018-2033
  - Table 19. Germany Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 20. Germany Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 21. Germany Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 22. The UK Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 23. The UK Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 24. The UK Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 25. France Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 26. France Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 27. France Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 28. Spain Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 29. Spain Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 30. Spain Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 31. Italy Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 32. Italy Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 33. Italy Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 34. Russia Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 35. Russia Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 36. Russia Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 37. Netherlands Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 38. Netherlands Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 39. Netherlands Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 40. Rest of Europe Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 41. Rest of Europe Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 42. Rest of Europe Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 43. Asia Pacific Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 44. Asia Pacific Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 45. Asia Pacific Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 46. Asia Pacific Lung Disease Therapeutics Market Value (US$ Mn), By Country, 2018-2033
  - Table 47. China Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 48. China Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 49. China Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 50. India Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 51. Global Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 52. Global Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 53. Japan Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 54. Japan Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 55. Japan Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 56. South Korea Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 57. South Korea Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 58. South Korea Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 59. New Zealand Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 60. New Zealand Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 61. New Zealand Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 62. Singapore Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 63. Singapore Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 64. Singapore Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 65. Thailand Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 66. Thailand Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 67. Thailand Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 68. Vietnam Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 69. Vietnam Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 70. Vietnam Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 71. Rest of Asia Pacific Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 72. Rest of Asia Pacific Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 73. Rest of Asia Pacific Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 74. Latin America Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 75. Latin America Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 76. Latin America Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 77. Latin America Lung Disease Therapeutics Market Value (US$ Mn), By Country, 2018-2033
  - Table 78. Brazil Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 79. Brazil Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 80. Brazil Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 81. Mexico Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 82. Mexico Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 83. Mexico Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 84. Rest of Latin America Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 85. Rest of Latin America Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 86. Rest of Latin America Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 87. Middle East & Africa Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 88. Middle East & Africa Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 89. Middle East & Africa Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 90. Middle East & Africa Lung Disease Therapeutics Market Value (US$ Mn), By Country, 2018-2033
  - Table 91. South Africa Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 92. South Africa Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 93. South Africa Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 94. Saudi Arabia Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 95. Saudi Arabia Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 96. Saudi Arabia Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 97. UAE Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 98. UAE Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 99. UAE Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
  - Table 100. Rest of Middle East & Africa Lung Disease Therapeutics Market Value (US$ Mn), By Disease Type, 2018-2033
  - Table 101. Rest of Middle East & Africa Lung Disease Therapeutics Market Value (US$ Mn), By Treatment Type, 2018-2033
  - Table 102. Rest of Middle East & Africa Lung Disease Therapeutics Market Value (US$ Mn), By Distribution Channel, 2018-2033
- List of Figures
  - Figure 1. Global Lung Disease Therapeutics Market Snapshot: Market Value (US$ Mn), 2018-2033
  - Figure 2. Opportunity Map
  - Figure 3. Opportunity Orbit
  - Figure 4. Regional Market Share and BPS Analysis in Lung Disease Therapeutics Market
  - Figure 5. Global Lung Disease Therapeutics Market Analysis, By Disease Type, 2018, 2023 and 2033
  - Figure 6. Global Lung Disease Therapeutics Market Attractiveness Analysis, By Disease Type
  - Figure 7. Global Lung Disease Therapeutics Market Analysis, By Treatment Type, 2018, 2023 and 2033
  - Figure 8. Global Lung Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
  - Figure 9. Global Lung Disease Therapeutics Market Analysis, By Distribution Channel, 2018, 2023 and 2033
  - Figure 10. Global Lung Disease Therapeutics Market Attractiveness Analysis, By Distribution Channel
  - Figure 11. North America Lung Disease Therapeutics Market Analysis, By Disease Type, 2018, 2023 and 2033
  - Figure 12. North America Lung Disease Therapeutics Market Attractiveness Analysis, By Disease Type
  - Figure 13. North America Lung Disease Therapeutics Market (US$ Mn), by Asthma, 2018-2033
  - Figure 14. North America Lung Disease Therapeutics Market (US$ Mn), by COPD, 2018-2033
  - Figure 15. North America Lung Disease Therapeutics Market (US$ Mn), by Lung Cancer, 2018-2033
  - Figure 16. North America Lung Disease Therapeutics Market (US$ Mn), by Other Diseases, 2018-2033
  - Figure 17. North America Lung Disease Therapeutics Market Analysis, By Treatment Type, 2018, 2023 and 2033
  - Figure 18. North America Lung Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
  - Figure 19. North America Lung Disease Therapeutics Market (US$ Mn), by Drugs, 2018-2033
  - Figure 20. North America Lung Disease Therapeutics Market (US$ Mn), by Bronchodilators, 2018-2033
  - Figure 21. North America Lung Disease Therapeutics Market (US$ Mn), by Antibiotics, 2018-2033
  - Figure 22. North America Lung Disease Therapeutics Market (US$ Mn), by Anti-inflammatory Agents, 2018-2033
  - Figure 23. North America Lung Disease Therapeutics Market (US$ Mn), by Oxygen Therapy, 2018-2033
  - Figure 24. North America Lung Disease Therapeutics Market (US$ Mn), by Other Treatment Types, 2018-2033
  - Figure 25. North America Lung Disease Therapeutics Market Analysis, By Distribution Channel, 2018, 2023 and 2033
  - Figure 26. North America Lung Disease Therapeutics Market Attractiveness Analysis, By Distribution Channel
  - Figure 27. North America Lung Disease Therapeutics Market (US$ Mn), by Retail Pharmacies, 2018-2033
  - Figure 28. North America Lung Disease Therapeutics Market (US$ Mn), by Hospital Pharmacies, 2018-2033
  - Figure 29. North America Lung Disease Therapeutics Market (US$ Mn), by Online Pharmacies, 2018-2033
  - Figure 30. North America Lung Disease Therapeutics Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 31. North America Lung Disease Therapeutics Market Attractiveness Analysis, By Country
  - Figure 32. Europe Lung Disease Therapeutics Market Analysis, By Disease Type, 2018, 2023 and 2033
  - Figure 33. Europe Lung Disease Therapeutics Market Attractiveness Analysis, By Disease Type
  - Figure 34. Europe Lung Disease Therapeutics Market (US$ Mn), by Asthma, 2018-2033
  - Figure 35. Europe Lung Disease Therapeutics Market (US$ Mn), by COPD, 2018-2033
  - Figure 36. Europe Lung Disease Therapeutics Market (US$ Mn), by Lung Cancer, 2018-2033
  - Figure 37. Europe Lung Disease Therapeutics Market (US$ Mn), by Other Diseases, 2018-2033
  - Figure 38. Europe Lung Disease Therapeutics Market Analysis, By Treatment Type, 2018, 2023 and 2033
  - Figure 39. Europe Lung Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
  - Figure 40. Europe Lung Disease Therapeutics Market (US$ Mn), by Drugs, 2018-2033
  - Figure 41. Europe Lung Disease Therapeutics Market (US$ Mn), by Bronchodilators, 2018-2033
  - Figure 42. Europe Lung Disease Therapeutics Market (US$ Mn), by Antibiotics, 2018-2033
  - Figure 43. Europe Lung Disease Therapeutics Market (US$ Mn), by Anti-inflammatory Agents, 2018-2033
  - Figure 44. Europe Lung Disease Therapeutics Market (US$ Mn), by Oxygen Therapy, 2018-2033
  - Figure 45. Europe Lung Disease Therapeutics Market (US$ Mn), by Other Treatment Types, 2018-2033
  - Figure 46. Europe Lung Disease Therapeutics Market Analysis, By Distribution Channel, 2018, 2023 and 2033
  - Figure 47. Europe Lung Disease Therapeutics Market Attractiveness Analysis, By Distribution Channel
  - Figure 48. Europe Lung Disease Therapeutics Market (US$ Mn), by Retail Pharmacies, 2018-2033
  - Figure 49. Europe Lung Disease Therapeutics Market (US$ Mn), by Hospital Pharmacies, 2018-2033
  - Figure 50. Europe Lung Disease Therapeutics Market (US$ Mn), by Online Pharmacies, 2018-2033
  - Figure 51. Europe Lung Disease Therapeutics Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 52. Europe Lung Disease Therapeutics Market Attractiveness Analysis, By Country
  - Figure 53. Asia Pacific Lung Disease Therapeutics Market Analysis, By Disease Type, 2018, 2023 and 2033
  - Figure 54. Asia Pacific Lung Disease Therapeutics Market Attractiveness Analysis, By Disease Type
  - Figure 55. Asia Pacific Lung Disease Therapeutics Market (US$ Mn), by Asthma, 2018-2033
  - Figure 56. Asia Pacific Lung Disease Therapeutics Market (US$ Mn), by COPD, 2018-2033
  - Figure 57. Asia Pacific Lung Disease Therapeutics Market (US$ Mn), by Lung Cancer, 2018-2033
  - Figure 58. Asia Pacific Lung Disease Therapeutics Market (US$ Mn), by Other Diseases, 2018-2033
  - Figure 59. Asia Pacific Lung Disease Therapeutics Market Analysis, By Treatment Type, 2018, 2023 and 2033
  - Figure 60. Asia Pacific Lung Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
  - Figure 61. Asia Pacific Lung Disease Therapeutics Market (US$ Mn), by Drugs, 2018-2033
  - Figure 62. Asia Pacific Lung Disease Therapeutics Market (US$ Mn), by Bronchodilators, 2018-2033
  - Figure 63. Asia Pacific Lung Disease Therapeutics Market (US$ Mn), by Antibiotics, 2018-2033
  - Figure 64. Asia Pacific Lung Disease Therapeutics Market (US$ Mn), by Anti-inflammatory Agents, 2018-2033
  - Figure 65. Asia Pacific Lung Disease Therapeutics Market (US$ Mn), by Oxygen Therapy, 2018-2033
  - Figure 66. Asia Pacific Lung Disease Therapeutics Market (US$ Mn), by Other Treatment Types, 2018-2033
  - Figure 67. Asia Pacific Lung Disease Therapeutics Market Analysis, By Distribution Channel, 2018, 2023 and 2033
  - Figure 68. Asia Pacific Lung Disease Therapeutics Market Attractiveness Analysis, By Distribution Channel
  - Figure 69. Asia Pacific Lung Disease Therapeutics Market (US$ Mn), by Retail Pharmacies, 2018-2033
  - Figure 70. Asia Pacific Lung Disease Therapeutics Market (US$ Mn), by Hospital Pharmacies, 2018-2033
  - Figure 71. Asia Pacific Lung Disease Therapeutics Market (US$ Mn), by Online Pharmacies, 2018-2033
  - Figure 72. Asia Pacific Lung Disease Therapeutics Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 73. Asia Pacific Lung Disease Therapeutics Market Attractiveness Analysis, By Country
  - Figure 74. Latin America Lung Disease Therapeutics Market Analysis, By Disease Type, 2018, 2023 and 2033
  - Figure 75. Latin America Lung Disease Therapeutics Market Attractiveness Analysis, By Disease Type
  - Figure 76. Latin America Lung Disease Therapeutics Market (US$ Mn), by Asthma, 2018-2033
  - Figure 77. Latin America Lung Disease Therapeutics Market (US$ Mn), by COPD, 2018-2033
  - Figure 78. Latin America Lung Disease Therapeutics Market (US$ Mn), by Lung Cancer, 2018-2033
  - Figure 79. Latin America Lung Disease Therapeutics Market (US$ Mn), by Other Diseases, 2018-2033
  - Figure 80. Latin America Lung Disease Therapeutics Market Analysis, By Treatment Type, 2018, 2023 and 2033
  - Figure 81. Latin America Lung Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
  - Figure 82. Latin America Lung Disease Therapeutics Market (US$ Mn), by Drugs, 2018-2033
  - Figure 83. Latin America Lung Disease Therapeutics Market (US$ Mn), by Bronchodilators, 2018-2033
  - Figure 84. Latin America Lung Disease Therapeutics Market (US$ Mn), by Antibiotics, 2018-2033
  - Figure 85. Latin America Lung Disease Therapeutics Market (US$ Mn), by Anti-inflammatory Agents, 2018-2033
  - Figure 86. Latin America Lung Disease Therapeutics Market (US$ Mn), by Oxygen Therapy, 2018-2033
  - Figure 87. Latin America Lung Disease Therapeutics Market (US$ Mn), by Other Treatment Types, 2018-2033
  - Figure 88. Latin America Lung Disease Therapeutics Market Analysis, By Distribution Channel, 2018, 2023 and 2033
  - Figure 89. Latin America Lung Disease Therapeutics Market Attractiveness Analysis, By Distribution Channel
  - Figure 90. Latin America Lung Disease Therapeutics Market (US$ Mn), by Retail Pharmacies, 2018-2033
  - Figure 91. Latin America Lung Disease Therapeutics Market (US$ Mn), by Hospital Pharmacies, 2018-2033
  - Figure 92. Latin America Lung Disease Therapeutics Market (US$ Mn), by Online Pharmacies, 2018-2033
  - Figure 93. Latin America Lung Disease Therapeutics Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 94. Latin America Lung Disease Therapeutics Market Attractiveness Analysis, By Country
  - Figure 95. Middle East & Africa Lung Disease Therapeutics Market Analysis, By Disease Type, 2018, 2023 and 2033
  - Figure 96. Middle East & Africa Lung Disease Therapeutics Market Attractiveness Analysis, By Disease Type
  - Figure 97. Middle East & Africa Lung Disease Therapeutics Market (US$ Mn), by Asthma, 2018-2033
  - Figure 98. Middle East & Africa Lung Disease Therapeutics Market (US$ Mn), by COPD, 2018-2033
  - Figure 99. Middle East & Africa Lung Disease Therapeutics Market (US$ Mn), by Lung Cancer, 2018-2033
  - Figure 100. Middle East & Africa Lung Disease Therapeutics Market (US$ Mn), by Other Diseases, 2018-2033
  - Figure 101. Middle East & Africa Lung Disease Therapeutics Market Analysis, By Treatment Type, 2018, 2023 and 2033
  - Figure 102. Middle East & Africa Lung Disease Therapeutics Market Attractiveness Analysis, By Treatment Type
  - Figure 103. Middle East & Africa Lung Disease Therapeutics Market (US$ Mn), by Drugs, 2018-2033
  - Figure 104. Middle East & Africa Lung Disease Therapeutics Market (US$ Mn), by Bronchodilators, 2018-2033
  - Figure 105. Middle East & Africa Lung Disease Therapeutics Market (US$ Mn), by Antibiotics, 2018-2033
  - Figure 106. Middle East & Africa Lung Disease Therapeutics Market (US$ Mn), by Anti-inflammatory Agents, 2018-2033
  - Figure 107. Middle East & Africa Lung Disease Therapeutics Market (US$ Mn), by Oxygen Therapy, 2018-2033
  - Figure 108. Middle East & Africa Lung Disease Therapeutics Market (US$ Mn), by Other Treatment Types, 2018-2033
  - Figure 109. Middle East & Africa Lung Disease Therapeutics Market Analysis, By Distribution Channel, 2018, 2023 and 2033
  - Figure 110. Middle East & Africa Lung Disease Therapeutics Market Attractiveness Analysis, By Distribution Channel
  - Figure 111. Middle East & Africa Lung Disease Therapeutics Market (US$ Mn), by Retail Pharmacies, 2018-2033
  - Figure 112. Middle East & Africa Lung Disease Therapeutics Market (US$ Mn), by Hospital Pharmacies, 2018-2033
  - Figure 113. Middle East & Africa Lung Disease Therapeutics Market (US$ Mn), by Online Pharmacies, 2018-2033
  - Figure 114. Middle East & Africa Lung Disease Therapeutics Market Analysis, By Country, 2018, 2023 and 2033
  - Figure 115. Middle East & Africa Lung Disease Therapeutics Market Attractiveness Analysis, By Country
- GlaxoSmithKline
- Boehringer Ingelheim
- AstraZeneca Plc Company Profile
- Novartis AG Company Profile
- Sanofi Company Profile
- Cipla Limited Company Profile
- Hoffman La Roche
- Teva Pharmaceuticals
- Astellas Pharma, Inc Company Profile
- Other Key Players
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)